Skip to content

Insider · CIK 0001889712

Eddie Joe Sullivan

presidentofficerdirectorceo

Files at SABS (SAB Biotherapeutics, Inc.). First filing Dec 8, 2023, latest Dec 8, 2023.

In brief

Eddie Joe Sullivan files SEC Form 4 as president, director and CEO at SABS (SAB Biotherapeutics, Inc.). Since Dec 8, 2023, Eddie Joe Sullivan has reported 1 open-market buy worth $1,531 and 0 open-market sells worth $0, the latest filed on Dec 8, 2023.

A track record needs three past buys with six months of prices behind them; Eddie Joe Sullivan has 0, so none is measured yet.

The newest scored trade: bought $1,531 of SABS on Dec 7, 2023, filed Dec 8, 2023, scored 35 (weak).

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$1,531 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
35Weak
SABSbuy 3
SAB Biotherapeutics, Inc.
$1,531
1,740 shares
+0%-

Transactions

Every row this insider has filed, 3 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Feb 3, 2026SABS
SAB Biotherapeutics, Inc.
AGrant or award
Stock option (right to buy)derivative
+3,000,000$0.00$03,000,000Feb 5, 2026
Aug 26, 2025SABS
SAB Biotherapeutics, Inc.
AGrant or award
Stock Option (right to buy)derivative
+3,000,000$0.00$03,000,000Aug 28, 2025
Dec 7, 2023SABS
SAB Biotherapeutics, Inc.
POpen-market purchase
Common Stock
+1,740$0.88$1,5315,232,304Dec 8, 2023

Questions about Eddie Joe Sullivan

Answered from the filings on this page, as of the latest one.

Is Eddie Joe Sullivan buying or selling?

Not in the last 12 months. Eddie Joe Sullivan's latest open-market trade on SEC Form 4 was bought $1,531 of SABS on Dec 7, 2023.

How did Eddie Joe Sullivan's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Eddie Joe Sullivan has 0.

Where does Eddie Joe Sullivan file Form 4?

Eddie Joe Sullivan has filed Form 4 at SABS (SAB Biotherapeutics, Inc.) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Eddie Joe Sullivan: insider trades and track record | InsiderTell